Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer center

OBJECTIVE: To assess overall survival of women with cervical cancer and describe prognostic factors associated. METHODS: A total of 3,341 cases of invasive cervical cancer diagnosed at the Brazilian Cancer Institute, Rio de Janeiro, southeastern Brazil, between 1999 and 2004 were selected. Clinical...

Full description

Bibliographic Details
Main Authors: Claudio Calazan do Carmo, Ronir Raggio Luiz
Format: Article
Language:English
Published: Universidade de São Paulo
Series:Revista de Saúde Pública
Subjects:
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102011000400004&lng=en&tlng=en
id doaj-4014483aad9b4e34867cb1057ce4013d
record_format Article
spelling doaj-4014483aad9b4e34867cb1057ce4013d2020-11-25T02:52:22ZengUniversidade de São PauloRevista de Saúde Pública0034-89101518-8787454661667S0034-89102011000400004Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer centerClaudio Calazan do Carmo0Ronir Raggio Luiz1Instituto Nacional de CâncerUniversidade Federal do Rio de JaneiroOBJECTIVE: To assess overall survival of women with cervical cancer and describe prognostic factors associated. METHODS: A total of 3,341 cases of invasive cervical cancer diagnosed at the Brazilian Cancer Institute, Rio de Janeiro, southeastern Brazil, between 1999 and 2004 were selected. Clinical and pathological characteristics and follow-up data were collected. There were performed a survival analysis using Kaplan-Meier curves and a multivariate analysis through Cox model. RESULTS: Of all cases analyzed, 68.3% had locally advanced disease at the time of diagnosis. The 5-year overall survival was 48%. After multivariate analysis, tumor staging at diagnosis was the single variable significantly associated with prognosis (p<0.001). There was seen a dose-response relationship between mortality and clinical staging, ranging from 27.8 to 749.6 per 1,000 cases-year in women stage I and IV, respectively. CONCLUSIONS: The study showed that early detection through prevention programs is crucial to increase cervical cancer survival.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102011000400004&lng=en&tlng=enneoplasias do colo do úterodetecção precoce de câncerdiagnóstico tardioanálise de sobrevida
collection DOAJ
language English
format Article
sources DOAJ
author Claudio Calazan do Carmo
Ronir Raggio Luiz
spellingShingle Claudio Calazan do Carmo
Ronir Raggio Luiz
Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer center
Revista de Saúde Pública
neoplasias do colo do útero
detecção precoce de câncer
diagnóstico tardio
análise de sobrevida
author_facet Claudio Calazan do Carmo
Ronir Raggio Luiz
author_sort Claudio Calazan do Carmo
title Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer center
title_short Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer center
title_full Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer center
title_fullStr Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer center
title_full_unstemmed Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer center
title_sort survival of a cohort of women with cervical cancer diagnosed in a brazilian cancer center
publisher Universidade de São Paulo
series Revista de Saúde Pública
issn 0034-8910
1518-8787
description OBJECTIVE: To assess overall survival of women with cervical cancer and describe prognostic factors associated. METHODS: A total of 3,341 cases of invasive cervical cancer diagnosed at the Brazilian Cancer Institute, Rio de Janeiro, southeastern Brazil, between 1999 and 2004 were selected. Clinical and pathological characteristics and follow-up data were collected. There were performed a survival analysis using Kaplan-Meier curves and a multivariate analysis through Cox model. RESULTS: Of all cases analyzed, 68.3% had locally advanced disease at the time of diagnosis. The 5-year overall survival was 48%. After multivariate analysis, tumor staging at diagnosis was the single variable significantly associated with prognosis (p<0.001). There was seen a dose-response relationship between mortality and clinical staging, ranging from 27.8 to 749.6 per 1,000 cases-year in women stage I and IV, respectively. CONCLUSIONS: The study showed that early detection through prevention programs is crucial to increase cervical cancer survival.
topic neoplasias do colo do útero
detecção precoce de câncer
diagnóstico tardio
análise de sobrevida
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102011000400004&lng=en&tlng=en
work_keys_str_mv AT claudiocalazandocarmo survivalofacohortofwomenwithcervicalcancerdiagnosedinabraziliancancercenter
AT ronirraggioluiz survivalofacohortofwomenwithcervicalcancerdiagnosedinabraziliancancercenter
_version_ 1724730454105391104